• SENSEX
    NIFTY 50
Business

Lupin eyes European market next for its biosimilar bet

Updated : October 11, 2019 08:34 PM IST

Company says it is confident of a good run in Europe owing to limited competition
Europe will be the second regulated market for Lupin’s Etanercept after Japan
Company expects to launch Etanercept biosimilar in Europe by July next year
Lupin eyes European market next for its biosimilar bet

You May Also Like

Live TV

recommended for you

Advertisement